Evidence map›Paper›PMID 39880414›Full record

Trial reportBMJ global health2025

An observational study evaluating the epidemiological and entomological impacts of piperonyl butoxide insecticide-treated nets (ITNs) compared to a combination of indoor residual spraying (IRS) plus standard pyrethroid-only ITNs in Amhara Region, Ethiopia, 2019-2023.

Kelly M Davis, Amha Worku, Meshesha Balkew, Peter Mumba, Sheleme Chibsa, Jon Eric Tongren, Gudissa Assefa, Achamyelesh Sisay, Dawit Teshome, Banchamlak Tegegne and 14 more

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kelly M DavisPMI Evolve Project, PATH, Washington, District of Columbia, USA kdavis@path.org.ORCID http://orcid.org/0009-0004-4625-0467
Amha WorkuPMI Evolve Project, Abt Global, Addis Ababa, Ethiopia.
Meshesha BalkewPMI Evolve Project, Abt Global, Addis Ababa, Ethiopia.
Peter MumbaU.S. President's Malaria Initiative, Addis Ababa, Ethiopia.
Sheleme ChibsaU.S. President's Malaria Initiative, Addis Ababa, Ethiopia.
Jon Eric TongrenU.S. President's Malaria Initiative, Addis Ababa, Ethiopia.
Gudissa AssefaMalaria and Other Vector-Borne Diseases Prevention and Control Desk, Federal Ministry of Health, Addis Ababa, Ethiopia.
Achamyelesh SisayMalaria and Other Vector-Borne Diseases Prevention and Control Desk, Federal Ministry of Health, Addis Ababa, Ethiopia.
Dawit TeshomePMI Evolve Project, Abt Global, Addis Ababa, Ethiopia.
Banchamlak TegegneAmhara Public Health Institute, Bahir Dar, Ethiopia.
Mastewal WorkuAmhara Public Health Institute, Bahir Dar, Ethiopia.
Mulat YimerBahir Dar University, Bahir Dar, Ethiopia.
Delenasaw YewhalawTropical and Infectious Disease Research Center, Jimma University, Jimma, Ethiopia.
Melissa YoshimizuUS President's Malaria Initiative, US Agency for International Development, Washington, District of Columbia, USA.
Sarah ZohdyUS President's Malaria Initiative, US Centers for Disease Control and Prevention, Entomology Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Atlanta, Georgia, USA.
Isabel SwamidossUS President's Malaria Initiative, US Centers for Disease Control and Prevention, Entomology Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Atlanta, Georgia, USA.
Carla MappUS President's Malaria Initiative, US Centers for Disease Control and Prevention, Entomology Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Atlanta, Georgia, USA.
Jimee HwangU.S. President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wendy InouyePATH, Seattle, Washington, USA.
Aklilu SeyoumPMI Evolve Project, Abt Global, Rockville, Maryland, USA.
Cecilia FlatleyPMI Evolve Project, Abt Global, Rockville, Maryland, USA.
Emily R HiltonPMI Evolve Project, PATH, Seattle, Washington, USA.ORCID http://orcid.org/0000-0001-9319-5203
Dereje DengelaPMI Evolve Project, Abt Global, Addis Ababa, Ethiopia.
Sarah M BurnettPMI Evolve Project, PATH, Washington, District of Columbia, USA.

Funding

PROVIDE RABBITS, RATS MICE, HAMSTERS GERBILS, GUINEA PIGS27307C0012 · NIEHS · PI BOLEN, WAYNE · 2007 to 2007
$1.0M
NIEHS NIH HHS 27307C0012
6 · The paper itself

Abstract

introductionNational malaria programmes must weigh the relative benefits of different vector control and elimination tools to prioritise resource allocation with the greatest impact. This study assesses the epidemiological and entomological impacts of piperonyl butoxide insecticide-treated nets (PBO ITN-only arm) compared with the combination of two annual non-pyrethroid indoor residual spraying (IRS) campaigns and standard pyrethroid ITNs (IRS+Standard Pyrethroid ITN arm) in the Amhara region of Ethiopia.

methodsAn open-label, stratified block-cluster randomised trial was designed to compare the impacts of the two intervention arms. ITN distribution took place from June to July 2021. IRS campaigns took place from June to July 2021 and again in June 2022. Confirmed malaria cases reported during the high transmission season (September to December) were compared in the 2 years before (2019 and 2020) vs the 2 years after (2021 and 2022) the 2021 campaigns. The difference in

resultsEstimated malaria cases decreased significantly by 53.6% in the postintervention period compared with preintervention in the IRS+Standard Pyrethroid ITN arm (95% CI -72.9%, -29.8%) and by 55.9% in the PBO ITN arm (95% CI -73.0%, -32.5%), with no significant difference between these two arms (95% CI -30.9%, 24.0%). From the first to the second season postintervention, cases decreased non-significantly in the IRS+Standard Pyrethroid ITN arm (incidence rate ratio (IRR) 0.94; 95% CI 0.66, 1.47) but increased significantly in the PBO ITN arm (IRR 1.98; 95% CI 1.49, 2.67). Postintervention vector density and IRD were not found to be significantly different between intervention arms in either 2021 (vector density: IRR 0.78; 95% CI 0.47, 1.31; IRD: IRR 0.80; 95% CI 0.37, 1.75) or 2022 (vector density: IRR 1.27; 95% CI 0.75, 2.12; IRD: IRR 1.02; 95% CI 0.45, 2.28).

conclusionThese findings suggest a positive impact of non-pyrethroid IRS deployed annually alongside standard pyrethroid ITNs in a setting of confirmed pyrethroid resistance. While an overall positive impact of PBO ITNs was detected, a waning impact of the nets 2 years postdistribution was observed.

Indexed as

InsecticidesInsecticide-Treated BednetsMalariaMosquito ControlPiperonyl ButoxidePyrethrinsAdultAnimalsAnophelesEthiopiaFemaleHumansMaleMosquito VectorsInsecticidesPiperonyl ButoxidePyrethrinsEpidemiologyMalariaMedical entomologyPublic Health

Identifiers

PMID39880414
PMCPMC11781093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.